Anito, Ashley O.
HRN: 27-10-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/22/2025
05/29/2025
IV
58 Mg
Q 24
Neonatal Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes